Dihydroorotate

Europe PMC · fetched just now · sorted by publication date

1. 1
   A label-free supramolecular nanoassembly triggers multi-organelle crosstalk-dependent metastasis inhibition via nuclear ROS-HDAC2 axis.

   Wang R, Zou L, Mi D, Wang C, Song Z, Liu T, Zhao M, Wang D, Shi S. · 2026-09-20

   open access unreviewed
2. 2
   Nanoparticle-based therapeutic platforms for inflammatory disorders of the urinary system: Engineering local delivery, biointerface regulation, and smart responsive therapy.

   Wang W, Ma J, Hou C, Chen J, Ni K. · 2026-09-16

   open access unreviewed
3. 3
   Ferroptosis: significance to zoonotic diseases and therapeutic prospects.

   Tian L, Cheng X, Ni J, Yang R, Ouyang W, Qi T, Liu Q, Wang D, Chen H, Wang X. · 2026-08-25

   open access unreviewed
4. 4
   Research progress of ferroptosis in gynecological diseases.

   Chen W, Zhou W, Liu S. · 2026-06-19

   open access unreviewed
5. 5
   PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators.

   Periyasamy S, Jarrett T, Truong J, Skouta R. · 2026-03-26

   cited 1× open access unreviewed
6. 6
   FDA-approved IMPDH inhibitors synergize with ribavirin to inhibit respiratory syncytial virus by interfering with purine <i>de novo</i> synthesis.

   Hu H, Wang Q, Ai Q, Zhou P, He Y, Ye Z, Ma K, Zhou M, Huang S, Wang L, Qi N, Xiao G, Wang S. · 2026-03-17

   cited 3× open access unreviewed
7. 7
   Antitumor activity and structure-activity relationship of poly (ADP-ribose) polymerase (PARP)-based dual inhibitors.

   Yang C, Shang Y, Li X, Li J, Li H, Han J. · 2025-12-15

   cited 1× open access unreviewed
8. 8
   Tumor‑immune spatiotemporal co‑evolution: A new paradigm for understanding and overcoming therapy resistance in metastatic castration‑resistant prostate cancer (Review).

   Yan L, Sun X, Su P. · 2026-09-25

   open access unreviewed
9. 9
   Arginine metabolism, polyamine homeostasis and ferroptosis in cancer: Molecular links and therapeutic opportunities (Review).

   Dong X, Hou Y, Shao J, Zhu H, Liu J. · 2026-09-18

   open access unreviewed
10. 10
    Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma.

    Ouyang W, Wang J, Chen J, Fang Z, Wei T, Qian J, Gui S. · 2026-09-13

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.